DOC vs SBAC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

DOC

51.5
AI Score
VS
DOC Wins

SBAC

38.0
AI Score

Investment Advisor Scores

DOC

52score
Recommendation
HOLD

SBAC

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric DOC SBAC Winner
Forward P/E 169.4915 20.79 SBAC
PEG Ratio 4.0809 11.5496 DOC
Revenue Growth 16.3% -2.5% DOC
Earnings Growth 68.2% -0.5% DOC
Tradestie Score 51.5/100 38.0/100 DOC
Profit Margin 12.3% 34.5% SBAC
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY DOC

Relative Price Performance (Last 90 Days)

DOC 1M: +7.7% · 3M: -1.2% SBAC 1M: +3.9% · 3M: +4.6%

Current Technical Phase

DOC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 61.4 · Price: $20.41

SBAC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 60

RSI (14): 59.8 · Price: $191.43

Fundamentals Snapshot

Metric DOC SBAC
Market Cap — —
Forward P/E 145.8 24.2
Trailing P/E 37.5 20.6
Revenue (TTM) — —
Revenue Growth 0.2% 0.0%
Gross Margin 0.6% 0.7%
Operating Margin 0.1% 0.5%
EPS 0.55 9.26
Dividend Yield 0.06% 0.03%

Frequently Asked Questions

Based on our detailed analysis, DOC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.